![Lyssa Friedman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Lyssa Friedman formerly worked at Veracyte, Inc., as Senior Director-Clinical Programs from 2008 to 2014 and OncoCyte Corp., as Vice President-Clinical & Regulatory Affairs from 2014 to 2018.
Ms. Friedman received her graduate degree from the University of San Francisco.
Anciens postes connus de Lyssa Friedman
| Sociétés | Poste | Fin |
|---|---|---|
| INSIGHT MOLECULAR DIAGNOSTICS INC. | Conseiller Juridique Général | 01/01/2018 |
| VERACYTE, INC. | Directeur Technique/Scientifique/R&D | 10/08/2009 |
Formation de Lyssa Friedman
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
33
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Veracyte, Inc.
 Veracyte, Inc. Medical SpecialtiesHealth Technology Discovers, develops and commercializes diagnostic products & biopharmaceutical services | Health Technology |
University of San Francisco
 University of San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OncoCyte Corp.
 OncoCyte Corp. BiotechnologyHealth Technology Focuses on the discovery, development and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer | Health Technology |
